Last reviewed · How we verify

Balance, Fresenius Medical Care, Germany

Kyungpook National University Hospital · FDA-approved active Small molecule Quality 0/100

Balance, Fresenius Medical Care, Germany is a Small molecule drug developed by Kyungpook National University Hospital. It is currently FDA-approved. Also known as: Balance, Fresenius Medical Care.

At a glance

Generic nameBalance, Fresenius Medical Care, Germany
Also known asBalance, Fresenius Medical Care
SponsorKyungpook National University Hospital
ModalitySmall molecule
PhaseFDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Balance, Fresenius Medical Care, Germany

What is Balance, Fresenius Medical Care, Germany?

Balance, Fresenius Medical Care, Germany is a Small molecule drug developed by Kyungpook National University Hospital.

Who makes Balance, Fresenius Medical Care, Germany?

Balance, Fresenius Medical Care, Germany is developed and marketed by Kyungpook National University Hospital (see full Kyungpook National University Hospital pipeline at /company/kyungpook-national-university-hospital).

Is Balance, Fresenius Medical Care, Germany also known as anything else?

Balance, Fresenius Medical Care, Germany is also known as Balance, Fresenius Medical Care.

What development phase is Balance, Fresenius Medical Care, Germany in?

Balance, Fresenius Medical Care, Germany is FDA-approved (marketed).

Related